Treatment of painful peripheral neuropathy

Neurologic Clinics

Volumn 31, Issue 2, 2013, Pages 377-403

  Trivedi, Jaya R ^a   Silvestri, Nicholas J ^b   Wolfe, Gil I ^b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

Author keywords

Anticonvulsants; Antidepressants; Neuropathic pain; Opiates; Peripheral neuropathy

Indexed keywords

4 AMINOBUTYRIC ACID; AMFEBUTAMONE; AMITRIPTYLINE; CANNABIS; CAPSAICIN; CARBAMAZEPINE; CITALOPRAM; CLOMIPRAMINE; DESIPRAMINE; DULOXETINE; FANATREX; FLUOXETINE; GABAPENTIN; GABAPENTIN ENACARBIL; GABARONE; HARKOSERIDE; IMIPRAMINE; LAMOTRIGINE; LEVORPHANOL; LIDOCAINE; MAPROTILINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NORTRIPTYLINE; PAROXETINE; PREGABALIN; RYBIX; SEROTONIN UPTAKE INHIBITOR; TOPIRAGEN; TOPIRAMATE; TRAMADOL; TRICYCLIC ANTIDEPRESSANT AGENT; UNCLASSIFIED DRUG; UNINDEXED DRUG; VALPROATE SEMISODIUM; VALPROIC ACID; VENLAFAXINE; VOLTAGE GATED SODIUM CHANNEL;

ANOREXIA; ASTHENIA; BIOAVAILABILITY; CLINICAL FEATURE; CLINICAL TRIAL (TOPIC); CLOSED ANGLE GLAUCOMA; CONFUSION; CONSTIPATION; DIABETIC NEUROPATHY; DIARRHEA; DIPLOPIA; DISEASES; DIZZINESS; DROWSINESS; DRUG CAPSULE; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG ERUPTION; DRUG INDICATION; DRUG SAFETY; DRUG TOLERABILITY; FATIGUE; GAIT DISORDER; HEADACHE; HEART ARRHYTHMIA; HUMAN; HYPERALGESIA; HYPONATREMIA; IMPOTENCE; INSOMNIA; IRRITABILITY; LEUKOPENIA; LIBIDO DISORDER; LIKERT SCALE; LIVER DYSFUNCTION; MCGILL PAIN QUESTIONNAIRE; MOOD DISORDER; NAUSEA; NAUSEA AND VOMITING; NERVE CONDUCTION; NEUROPATHIC PAIN; ORTHOSTATIC HYPOTENSION; PARESTHESIA; PATHOPHYSIOLOGY; PERIPHERAL EDEMA; PERIPHERAL NERVE; PERIPHERAL NEUROPATHY; POSTHERPETIC NEURALGIA; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SEDATION; SEIZURE; SENSORY NEUROPATHY; SEXUAL DYSFUNCTION; SIDE EFFECT; SOMNOLENCE; STEVENS JOHNSON SYNDROME; SWEATING; SYMPTOM; THROMBOCYTOPENIA; TRANSDERMAL PATCH; TREATMENT DURATION; TREATMENT WITHDRAWAL; TREMOR; TRIGEMINUS NEURALGIA; UNSTEADINESS; UPPER RESPIRATORY TRACT INFECTION; URINE RETENTION; URTICARIA; VISUAL ANALOG SCALE; WEAKNESS; WEIGHT GAIN; XEROSTOMIA;

ANALGESICS; ANTIDEPRESSIVE AGENTS; GAMMA-AMINOBUTYRIC ACID; HUMANS; NEURALGIA; PAIN MANAGEMENT; RANDOMIZED CONTROLLED TRIALS AS TOPIC; THIOPHENES;

EID: 84877104861     PISSN: 07338619     EISSN: 15579875     Source Type: Journal    
DOI: 10.1016/j.ncl.2013.01.003     Document Type: Review

References (126)

1. International Association for the Study of Pain. Taxonomy. Available at: Accessed November 20, 2012. http://www.iasp-pain.org/AM/Template.cfm%3fSection%3dPain_Defi.isplay.cfm%26ContentID%3d1728.
2. Carter G.T., Galer B.S. Advances in the management of neuropathic pain. Phys Med Rehabil Clin North Am 2001, 12:447-459.
3. Smith T.E., Chong M.S. Neuropathic pain. Hosp Med 2000, 61:760-766.
4. Galer B.S., Gianas A., Jensen M.P. Painful diabetic polyneuropathy: epidemiology, pain description, and quality of life. Diabetes Res Clin Pract 2000, 47:123-128.
5. Galer B.S. Painful polyneuropathy. Neurol Clin 1998, 16:791-811.
6. Periquet M.I., Novak V., Collins M.P., et al. Painful sensory neuropathy: prospective evaluation using skin biopsy. Neurology 2000, 53:1641-1647.
7. Lacomis D. Small-fiber neuropathy. Muscle Nerve 2002, 26:173-188.
8. Wolfe G.I., Baker N.S., Amato A.A., et al. Chronic cryptogenic sensory polyneuropathy: clinical and laboratory characteristics. Arch Neurol 1999, 56:540-547.
9. Holland N.R., Crawford T.O., Hauer P., et al. Small-fiber sensory neuropathies: clinical course and neuropathology of idiopathic cases. Ann Neurol 1998, 44:47-59.
10. Holland N.R. Idiopathic painful sensory neuropathy. J Clin Neuromuscul Dis 2001, 2:211-220.
11. Luciano C.A., Russell J.W., Banarjee T.K., et al. Physiological characterization of neuropathy in Fabry disease. Muscle Nerve 2002, 26:622-629.
12. Wolfe G.I., Barohn R.J. Cryptogenic sensory and sensorimotor polyneuropathies. Semin Neurol 1998, 18:105-111.
13. Simpson D.M., McArthur J.C., Olney R., et al. Lamotrigine for HIV-associated painful sensory neuropathies: a placebo-controlled trial. Neurology 2003, 60:1508-1514.
14. Woolf C.J., Mannion R.J. Neuropathic pain: aetiology, symptoms, mechanisms, and management. Lancet 1999, 353:1959-1964.
15. Ochoa J., Torebjork H.E., Culp W.J., et al. Abnormal spontaneous activity in single sensory nerve fibres in humans. Muscle Nerve 1982, 5:S74-S77.
16. Devor M. The pathophysiology of damaged peripheral nerves. Textbook of pain 1994, 79-100. Churchill Livingstone, Edinburgh (United Kingdom). P.D. Wall, R. Melzack (Eds.).
17. Bennett G. The role of the sympathetic nervous system in painful peripheral neuropathy. Pain 1991, 45:221-223.
18. Woolf C.J. Evidence for a central component of post-injury pain. Nature 1983, 306:686-688.
19. Gracely R.H., Lynch S.A., Bennett G.J. Painful neuropathy: altered central processing maintained dynamically by peripheral input. Pain 1992, 51:175-194.
20. Besson J.M. The neurobiology of pain. Lancet 1999, 353:1610-1615.
21. Galer B.S. Neuropathic pain of peripheral origin: advances in pharmacologic treatment. Neurology 1995, 45(Suppl 9):S17-S25.
22. Backonja M., Beydoun A., Edwards K.R., et al. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus. JAMA 1998, 280:1831-1836.
23. Harati Y., Gooch C., Swenson M., et al. Double-blind randomized trial of tramadol for the treatment of the pain of diabetic neuropathy. Neurology 1998, 50:1842-1846.
24. Max M.B., Lynch S.A., Muir J., et al. Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy. N Engl J Med 1992, 326:1250-1256.
25. Capsaicin Study Group Treatment of painful diabetic neuropathy with topical capsaicin: a multicenter, double-blind, vehicle-controlled study. Arch Intern Med 1991, 151:2225-2229.
26. Sindrup S.H., Gram L.F., BrØsen K., et al. The selective serotonin reuptake inhibitor paroxetine is effective in the treatment of diabetic neuropathy symptoms. Pain 1990, 42:135-144.
27. Kieburtz K., Simpson D., Yiannoutsos C., et al. A randomized trial of amitriptyline and mexiletine for painful neuropathy in HIV infection. Neurology 1998, 51:1682-1688.
28. Low P.A., Opfer-Gehrking T.L., Dyck P.J., et al. Double-blind placebo-controlled study of the application of capsaicin cream in chronic distal painful polyneuropathy. Pain 1995, 62:163-168.
29. Eisenberg E., Lurie Y., Braker C., et al. Lamotrigine reduces painful diabetic neuropathy: a randomized, controlled study. Neurology 2001, 57:505-509.
30. Semenchuk M.R., Sherman S., Davis B. Double-blind, randomized trial of bupropion SR for the treatment of neuropathic pain. Neurology 2001, 57:1583-1588.
31. Sindrup S.H., Jensen T.S. Efficacy of pharmacological treatments of neuropathic pain: an update and effect related to mechanism of drug action. Pain 1999, 83:389-400.
32. Chong M.S., Bajwa Z.H. Diagnosis and treatment of neuropathic pain. J Pain Symptom Manage 2003, 25:S4-S11.
33. Melzack R. The short-form McGill Pain Questionnaire. Pain 1987, 30:191-197.
34. Daut R.L., Cleeland C.S., Flanery R.C. Development of the Wisconsin Brief Pain Questionnaire to assess pain in cancer and other diseases. Pain 1983, 17:197-210.
35. Galer B.S., Jensen M.P. Development and preliminary validation of a pain measure specific to neuropathic pain: the Neuropathic Pain Scale. Neurology 1997, 48:332-338.
36. Calissi P.T., Jaber L.A. Peripheral diabetic neuropathy: current concepts of treatment. Ann Pharmacother 1995, 29:769-777.
37. Sindrup S.H., Jensen T.S. Pharmacologic treatment of pain in polyneuropathy. Neurology 2000, 55:915-920.
38. Vrethem M., Boivie J., Arnqvist H., et al. A comparison of amitriptyline and maprotiline in the treatment of painful polyneuropathy in diabetics and nondiabetics. Clin J Pain 1997, 13:313-323.
39. Max M.B., Kishore-Kumar R., Schafer S.C., et al. Efficacy of desipramine in painful diabetic neuropathy: a placebo-controlled trial. Pain 1991, 45:3-9.
40. Max M.B., Culnane M., Schafer S.C., et al. Amitriptyline relieves diabetic neuropathy pain in patients with normal or depressed mood. Neurology 1987, 37:589-596.
41. McQuay H.J., Tramèr M., Nye B.A., et al. A systematic review of antidepressants in neuropathic pain. Pain 1996, 68:217-227.
42. Sindrup S.H., Gram L.F., Skjold T., et al. Clomipramine vs desipramine vs placebo in the treatment of diabetic neuropathy symptoms: a double-blind cross-over study. Br J Clin Pharmacol 1990, 30:683-691.
43. Sindrup S.H., Tuxen C., Gram L.F., et al. Lack of effect of mianserin on the symptoms of diabetic neuropathy. Eur J Clin Pharmacol 1992, 43:251-255.
44. Shlay J.C., Chaloner K., Max M.B., et al. Acupuncture and amitriptyline for pain due to HIV-related peripheral neuropathy: a randomized controlled trial. JAMA 1998, 280:1590-1595.
45. Kvinesdal B., Molin J., FrØland A., et al. Imipramine treatment of painful diabetic neuropathy. JAMA 1984, 251:1727-1730.
46. Wolfe G.I., Barohn R.J. Painful peripheral neuropathy. Curr Treat Options Neurol 2002, 4:177-188.
47. Sindrup S.H., Bjerre U., Dejgaard A., et al. The selective serotonin reuptake inhibitor citalopram relieves the symptoms of diabetic neuropathy. Clin Pharmacol Ther 1992, 52:547-552.
48. Brasch-Anderson C., Moller M.U., Christiansen L., et al. A candidate gene study of serotonergic pathway genes and pain relief during treatment with escitalopram in patients with neuropathic pain shows significant association to serotonin receptor2C (HTR2C). Eur J Clin Pharmacol 2011, 67(11):1131-1137.
49. Goldstein D.J., Lu Y., Detke M.J., et al. Duloxetine vs. placebo in patients with painful diabetic neuropathy. Pain 2005, 116:109-118.
50. Raskin J., Pritchett Y.L., Wang F., et al. A double-blind randomized multicenter trial comparing duloxetine with placebo in the management of diabetic peripheral neuropathic pain. Pain Med 2005, 6:346-356.
51. Ascher J.A., Cole J.O., Colin J.N., et al. Bupropion: a review of its mechanism of antidepressant activity. J Clin Psychiatry 1995, 56:395-401.
52. Wolfe G.I., Hotz S.E., Barohn R.J. Treatment of painful peripheral neuropathy. J Clin Neuromuscul Dis 2002, 4:50-59.
53. Holliday S.M., Benfield P. Venlafaxine: a review of its pharmacology and therapeutic potential in depression. Drugs 1995, 49:280-294.
54. Kunz N.R., Goli V., Entsuah A.R. Venlafaxine extended release in the treatment of pain associated with diabetic neuropathy. Neurology 2000, 54(Suppl 3):A441. [abstract].
55. Simpson D.A. Gabapentin and venlafaxine for the treatment of painful diabetic neuropathy. J Clin Neuromuscul Dis 2001, 3:53-62.
56. Sindrup S.H., Bach F.W., Madsen C., et al. Venlafaxine versus imipramine in painful polyneuropathy: a randomized, controlled trial. Neurology 2003, 60:1284-1289.
57. Kuzniecky R., Ho S., Pan J., et al. Modulation of cerebral GABA by topiramate, lamotrigine, and gabapentin in healthy adults. Neurology 2002, 58:368-372.
58. Petroff O.A., Rothman D.L., Behar K.L., et al. The effect of gabapentin on brain gamma-aminobutyric acid in patients with epilepsy. Ann Neurol 1996, 39:95-99.
59. Taylor C.P., Gee N.S., Su T.Z., et al. A summary of mechanistic hypotheses of gabapentin pharmacology. Epilepsy Res 1998, 29:231-246.
60. Pandey C.K., Bose N., Garg G., et al. Gabapentin for the treatment of pain in Guillain-Barré syndrome: a double-blinded, placebo-controlled, crossover study. Anesth Analg 2002, 95:1719-1723.
61. Serpell M.G., Neuropathic Pain Study Group Gabapentin in neuropathic pain syndromes: a randomised double-blind, placebo-controlled trial. Pain 2002, 99:557-566.
62. Pandey C.K., Raza M., Tripathi M., et al. The comparative evaluation of gabapentin and carbamazepine for pain management in Guillain-Barré syndrome patients in the intensive care unit. Anesth Analg 2005, 101:220-225.
63. Morello C.M., Leckband S.G., Stoner C.P., et al. Randomized double-blind study comparing the efficacy of gabapentin with amitriptyline on diabetic peripheral neuropathy pain. Arch Intern Med 1999, 159:1931-1937.
64. Dallocchio C., Buffa C., Mazzarello P., et al. Gabapentin vs amitriptyline in painful diabetic neuropathic pain: an open-label pilot study. J Pain Symptom Manage 2000, 20:280-285.
65. Backonja M., Glanzman R.L. Gabapentin dosing for neuropathic pain: evidence from randomized, placebo-controlled clinical trials. Clin Ther 2003, 25:81-104.
66. Gorson K., Schott C., Herman R., et al. Gabapentin in the treatment of painful diabetic neuropathy: a placebo controlled, double blind, crossover trial. J Neurol Neurosurg Psychiatr 1999, 66:251-252.
67. Leach M.J., Marden C.M., Miller A.A. Pharmacological studies on lamotrigine, a novel potential antiepileptic drug: II. Neurochemical studies on the mechanism of action. Epilepsia 1986, 27:490-497.
68. McCleane G. 200 mg daily of lamotrigine has no analgesic effect in neuropathic pain: a randomized, double-blind, placebo-controlled trial. Pain 1999, 83:105-107.
69. Simpson D.M., Olney R., McArthur J.C., et al. A placebo-controlled trial of lamotrigine for painful HIV-associated neuropathy. Neurology 2000, 54:2115-2119.
70. Rao R.D., Flynn P.J., Sloan J.A., et al. Efficacy of lamotrigine in the management of chemotherapy-induced peripheral neuropathy: a phase 3 randomized, double-blind, placebo-controlled trial, N01C3. Cancer 2008, 112(12):2802-2808.
71. Edwards K.R., Glantz M.J., Button J., et al. Efficacy and safety of topiramate in the treatment of painful diabetic neuropathy: a double-blind, placebo-controlled study. Neurology 2000, 54(Suppl):A81. [abstract].
72. Thienel U., Neto W., Schwabe S.K., et al. Topiramate in painful diabetic polyneuropathy: findings from three double-blind, placebo-controlled trials. Acta Neurol Scand 2004, 110:221-231.
73. Raskin P., Donofrio P.D., Rosenthal N.R., et al. Topiramate vs placebo in painful diabetic neuropathy: analgesic and metabolic effects. Neurology 2004, 63:865-873.
74. Backonja M. Use of anticonvulsants for treatment of neuropathic pain. Neurology 2002, 59:S14-S17.
75. Mendell J.R., Sahenk Z. Painful sensory neuropathy. N Engl J Med 2003, 348:1243-1255.
76. Rull J.A., Quibrera R., González-Millán H., et al. Symptomatic treatment of peripheral diabetic neuropathy with carbamazepine (Tegretol): double blind crossover trial. Diabetologia 1969, 5:215-218.
77. Wilton T.D. Tegretol in the treatment of diabetic neuropathy. S Afr Med J 1974, 48:869-872.
78. May T.W., Korn-Merker E., Rambeck B. Clinical pharmacokinetics of oxcarbazepine. Clin Pharmacokinet 2003, 42:1023-1042.
79. Pellock J.M. Tricyclic anticonvulsants: safety and adverse effects. Epilepsy Behav 2002, 3:S14-S17.
80. Carrazana E., Mikoshiba I. Rationale and evidence for the use of oxcarbazepine in neuropathic pain. J Pain Symptom Manage 2003, 25:S31-S35.
81. Beydoun A., Shaibani A., Hopwood M., et al. Oxcarbazepine in painful diabetic neuropathy: results of a dose-ranging study. Acta Neurol Scand 2006, 113:395-404.
82. Grosskopf J., Mazzola J., Wan Y., et al. A randomized, placebo-controlled study of oxcarbazepine in painful diabetic neuropathy. Acta Neurol Scand 2006, 114:177-180.
83. Jensen T.S. Anticonvulsants in neuropathic pain: rationale and clinical evidence. Eur J Pain 2002, 6:61-68.
84. Kochar D.K., Jain N., Agarwal R.P., et al. Sodium valproate in the management of painful neuropathy in type 2 diabetes-a randomized placebo controlled study. Acta Neurol Scand 2002, 106:248-252.
85. Rosenstock J., Tuchman M., LaMoreaux L., et al. Pregabalin for the treatment of painful diabetic peripheral neuropathy: a double-blind, placebo-controlled trial. Pain 2004, 110:628-638.
86. Lesser H., Sharma U., LaMoreaux L., et al. Pregabalin relieves symptoms of painful diabetic neuropathy: a randomized controlled trial. Neurology 2004, 63:2104-2110.
87. Richter R.W., Portenoy R., Sharma U., et al. Relief of diabetic peripheral neuropathy with pregabalin: a randomized, placebo-controlled trial. J Pain 2005, 6:253-260.
88. Freynhagen R., Strojek K., Griesing T., et al. Efficacy of pregabalin in neuropathic pain evaluated in a 12-week, randomised, double-blind, multicentre, placebo-controlled trial of flexible- and fixed-dose regimens. Pain 2005, 115:254-263.
89. Sharma U., Griesing T., Emir B., et al. Time to onset of neuropathic pain reduction: a retrospective analysis of data from nine controlled trials of pregabalin for painful diabetic peripheral neuropathy and postherpetic neuralgia. Am J Ther 2010, 17(6):577-585.
90. Errington A.C., Stöhr T., Heers C., et al. The investigational anticonvulsant lacosamide selectively enhances slow inactivation of voltage-gated sodium channels. Mol Pharmacol 2008, 73:157-169.
91. Ziegler D., Hidvegi T., Gurieva I., et al. Efficacy and safety of lacosamide in painful diabetic neuropathy. Diabetes Care 2010, 33:839-841.
92. Shaibani A., Fares S., Selam J.L., et al. Lacosamide in painful diabetic neuropathy: an 18-week double-blind placebo-controlled trial. J Pain 2009, 10:818-828.
93. Wymer J.P., Simpson J., Sen D., et al. Efficacy and safety of lacosamide in diabetic neuropathic pain: an 18-week double-blind placebo-controlled trial of fixed-dose regimens. Clin J Pain 2009, 25:376-385.
94. Raffa R.B., Friderichs E., Reimann W., et al. Opioid and nonopioid components independently contribute to the mechanism of action of tramadol, an "atypical" opioid analgesic. J Pharmacol Exp Ther 1992, 260:275-285.
95. Richter W., Barth H., Flohe L., et al. Clinical investigation on the development of dependence during oral therapy with tramadol. Arzneimittelforschung 1985, 35:1742-1744.
96. Sindrup S.H., Andersen G., Madsen C., et al. Tramadol relieves pain and allodynia in polyneuropathy: a randomised, double-blind, controlled trial. Pain 1999, 83:85-90.
97. Harati Y., Gooch C., Swenson M., et al. Maintenance of long-term effectiveness of tramadol in treatment of the pain in diabetic neuropathy. J Diabetes Complications 2000, 14:65-70.
98. Gimbel J.S., Richards P., Portenoy R.K. Controlled-release oxycodone for pain in diabetic neuropathy: a randomized controlled study. Neurology 2003, 60:927-934.
99. Gilron I., Bailey J.M., Dongsheng T., et al. Morphine, gabapentin, or their combination for neuropathic pain. N Engl J Med 2005, 352:1324-1334.
100. Watson C.P., Babul N. Efficacy of oxycodone in neuropathic pain: a randomized trial in postherpetic neuralgia. Neurology 1998, 50:1837-1841.
101. Rowbotham M.C., Twilling L., Davies P.S., et al. Oral opioid therapy for chronic peripheral and central neuropathic pain. N Engl J Med 2003, 348:1223-1232.
102. Abrams D.I., Jay C.A., Shade S.B., et al. Cannabis in painful HIV-associated sensory neuropathy. A randomized placebo-controlled trial. Neurology 2007, 68:515-521.
103. Oskarsson P., Ljunggren J.G., Lins P.E., et al. Efficacy and safety of mexiletine in the treatment of painful diabetic neuropathy. Diabetes Care 1997, 20:1594-1597.
104. Dejgård A., Petersen P., Kastrup J. Mexiletine for treatment of chronic painful diabetic neuropathy. Lancet 1988, 1:9-11.
105. Stracke H., Meyer U.E., Schumacher H.E., et al. Mexiletine in the treatment of diabetic neuropathy. Diabetes Care 1992, 15:1550-1555.
106. Nishiyama K., Sakuta M. Mexiletine for painful alcoholic neuropathy. Intern Med 1995, 34:577-579.
107. Kemper C.A., Kent G., Burton S., et al. Mexiletine for HIV-infected patients with painful peripheral neuropathy: a double-blind, placebo-controlled, crossover treatment trial. J Acquir Immune Defic Syndr Hum Retrovirol 1998, 19:367-372.
108. Tandan R., Lewis G.A., Krusinski P.B., et al. Topical capsaicin in painful diabetic neuropathy. Diabetes Care 1992, 15:8-14.
109. Scheffler N.M., Sheitel P.L., Lipton M.N. Treatment of painful diabetic neuropathy with capsaicin 0.075-percent. J Am Podiatr Med Assoc 1991, 81:288-293.
110. Capsaicin Study Group Effect of treatment with capsaicin on daily activities of patients with painful diabetic neuropathy. Diabetes Care 1991, 15:159-165.
111. Paice J.A., Ferrans C.E., Lashley F.R., et al. Topical capsaicin in the management of HIV-associated peripheral neuropathy. J Pain Symptom Manage 2000, 19:45-52.
112. Nolano M., Simone D.A., Wendelschafer-Crabb G., et al. Topical capsaicin in humans: parallel loss of epidermal fibers and pain sensation. Pain 1999, 81:135-145.
113. Fitzgerald M. Capsaicin and sensory neurons: a review. Pain 1983, 15:109-130.
114. Simpson D.M., Brown S., Tobias J., et al. Controlled trial of high-concentration capsaicin patch for treatment of painful HIV neuropathy. Neurology 2008, 70:2305-2313.
115. Clifford D.B., Simpson D.M., Brown S., et al. A randomized, double-blind, controlled study of NGX-4010, a capsaicin 8% dermal patch, for the treatment of painful HIV-associated distal sensory polyneuropathy. J Acquir Immune Defic Syndr 2012, 59(2):126-133.
116. Ertas M., Sagduyu A., Arac N., et al. Use of levodopa to relieve pain from painful symmetrical diabetic polyneuropathy. Pain 1998, 75:257-259.
117. Nelson K.A., Park K.M., Robinovitz E., et al. High-dose oral dextromethorphan versus placebo in painful diabetic neuropathy and postherpetic neuralgia. Neurology 1997, 48:1212-1218.
118. Sang C.N., Booher S., Gilron I., et al. Dextromethorphan and memantine in painful diabetic neuropathy and postherpetic neuralgia: efficacy and dose-response trials. Anesthesiology 2002, 96:1053-1061.
119. Yuan R.Y., Sheu J.J., Yu J.M., et al. Botulinum toxin for diabetic neuropathic pain. A randomized double-blind crossover trial. Neurology 2009, 72:1473-1478.
120. Valensi P., Le Devehat C., Richard J.L., et al. A multicenter, double-blind, safety study of QR-333 for the treatment of symptomatic diabetic peripheral neuropathy: a preliminary report. J Diabetes Complications 2005, 19:247-253.
121. Ziegler D., Ametov A., Barinov A., et al. Oral treatment with α-lipoic acid improves symptomatic diabetic polyneuropathy: the SYDNEY 2 trial. Diabetes Care 2006, 29:2365-2370.
122. Cook R.J., Sackett D.L. The number needed to treat: a clinically useful measure of treatment effect. BMJ 1995, 310:452-454.
123. Wolfe G.I., Trivedi J.R. Painful peripheral neuropathy and its nonsurgical treatment. Muscle Nerve 2004, 30:3-19.
124. Rutkove S.B. A 52-year-old woman with disabling peripheral neuropathy: review of diabetic polyneuropathy. JAMA 2009, 302:1451-1458.
125. Bril V., England J., Franklin G.M., et al. Evidence-based guideline: treatment of painful peripheral neuropathy. Neurology 2011, 76:1758-1765.
126. Gilron I., Bailey J., Weaver D.F., et al. Patients' attitudes and prior treatments in neuropathic pain: a pilot study. Pain Res Manag 2002, 7:199-203.